Introduction Inhaled corticosteroids (ICSs) play an important role in lowering the risk of acute
exacerbation of chronic obstructive pulmonary disease (COPD). However, ICSs are known …

Clinicians should consider the long-term risks of pneumonia with the use of inhaled
corticosteroids in patients with COPD. Adequately powered long-term head-to-head trials …

Some studies suggest an association between onset and/or poor control of type 2 diabetes
mellitus and inhaled corticosteroid (ICS) therapy for chronic obstructive pulmonary disease …

Background Inhaled corticosteroids are increasingly being used in patients with chronic
obstructive lung disease (COPD), but their effectiveness is disputed. The aim of this study …

Current guidelines for the management of chronic obstructive pulmonary disease (COPD)
recommend limiting the use of inhaled corticosteroids (ICS) to patients with more severe …

Background: Clinical studies suggest that inhaled corticosteroids reduce exacerbations and
improve health status in chronic obstructive pulmonary disease (COPD). However, their …

Inhaled corticosteroids have a proven benefit in the management of asthma, but until
recently, their efficacy in non-asthmatic, smoking-related chronic obstructive pulmonary …

Inhaled corticosteroids (ICS) are important in reducing exacerbation frequency associated
with chronic obstructive pulmonary disease (COPD). However, little is known about the risk …

Background Conflicting findings exist on the benefit of withdrawal of inhaled corticosteroid
(ICS) in chronic obstructive pulmonary disease (COPD). We performed a quantitative …

Introduction Identifying the variables that guide decision-making in relation to the use of
inhaled corticosteroids (ICS) can contribute to the appropriate use of these drugs. The …